TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Kubator Therapeutics AB
Closing information (x1000 DKK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
1,735
|
1,932
|
1,696 |
| Financial expenses |
287
|
41
|
0 |
| Earnings before taxes |
950
|
1,142
|
580 |
| EBITDA |
1,147
|
1,116
|
549 |
| Total assets |
3,411
|
2,859
|
2,348 |
| Current assets |
2,343
|
1,709
|
1,216 |
| Current liabilities |
1,395
|
964
|
1,323 |
| Equity capital |
1,809
|
1,753
|
912 |
| - share capital |
33
|
33
|
35 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
53.0%
|
61.3%
|
38.8% |
| Turnover per employee |
1,735
|
1,932
|
1,696 |
| Profit as a percentage of turnover |
54.8%
|
59.1%
|
34.2% |
| Return on assets (ROA) |
36.3%
|
41.4%
|
24.7% |
| Current ratio |
168.0%
|
177.3%
|
91.9% |
| Return on equity (ROE) |
52.5%
|
65.1%
|
63.6% |
| Change turnover |
-201
|
355
|
522 |
| Change turnover % |
-10%
|
22%
|
44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.